Systemic Injection of FGF-2 Stimulates Endocortical Bone Modelling in SAMP6, a Murine Model of Low Turnover Osteopenia

Journal of Veterinary Medical Science

Volumn 61, Issue 8, 1999, Pages 869-875

  Nagai, Hirofumi ^a   Tsukuda, Ryoichi ^a   Yamasaki, Hideki ^a   Mayahara, Hiroshi ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Bone histomorphometry; Bone modelling; Osteoporosis; SAM

Indexed keywords

MURINAE;

FIBROBLAST GROWTH FACTOR 2; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REMODELING; DRUG EFFECT; HUMAN; MALE; METABOLIC BONE DISEASE; MOUSE; PATHOPHYSIOLOGY;

ANIMALS; BONE DISEASES, METABOLIC; BONE REMODELING; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MICE; OSTEOGENESIS; RECOMBINANT PROTEINS;

EID: 0033173019     PISSN: 7653697     EISSN: 1782155X     Source Type: Journal    
DOI: 10.1292/jvms.61.869     Document Type: Article

References (29)

1. Canalis, E., Centrella, M. and McCarthy, T. 1988. Effects of basic fibroblast growth factor on bone formation in vitro. J. Clin. Invest. 81: 1572-1577.
2. Deng. C., Wynshaw-Boris, A., Zhou, F., Kuo, A. and Leder, P. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84: 911-921.
3. Globus, R. K., Plouet, J. and Gospodarowicz, D. 1989. Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 124: 1539-1547.
4. Gowen, M. 1994. Cytokines and cellular interactions in the control of bone remodelling. pp. 77-114. In. Bone and Mineral Research/8 (Heersche, J. N. M. and Kanis, J. A. eds.), Elsevier, Tokyo.
5. Hanada, K., Dennis, J. E. and Caplan, A. I. 1997. Stimulatory effects of basic fibroblast growth factor and bone morphogenic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 12: 1606-1614.
6. Hauschka, P. V., Maurakos, A. E., Iafrati, M. D., Doleman, S. E. and Klagsbrun, M. 1986. Growth factors in bone matrix - Isolation of multiple types by affinity chromatography on heparin-sepharose. J. Biol. Chem. 261: 12665-12674.
7. Hurley, M. M., Abreu, C., Harrison, J. R., Lichtler, A. C., Raisz, L. G. and Kream, B. E. 1993. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268: 5588-5593.
8. Jee, W. S. S., Li, X. J., Inoue, J., Jee, K. W., Haba, T., Ke, H. Z., Setterberg, R. B. and Ma, Y. F. 1997. Histomorphometric assay of the growing bones. pp. 87-112. In: Handbook of Bone Morphometry (Takahashi, H. ed.), Nishimura Co., Ltd., Niigata.
9. Jilka, R. L., Weinstein, R. S., Takahashi, K., Parfitt, A. M. and Manolagas, S. C. 1996. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J. Clin. Invest. 97: 1732-1740.
10. Kajkenova, O., Lecka-Czernik, B., Gubrij, I., Hauser, S. P., Takahashi, K., Parfitt, A. M., Jilka, R. L., Manolagas, S. C. and Lipschitz, D. A. 1997. Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J. Bone Miner. Res. 12: 1772-1779.
11. Linkhart, T. A., Mohan, S. and Baylink, D. J. 1996. Growth factors for bone growth and repair: IGF, TGFβ and BMP. Bone 19: 1S-12S.
12. Martin, I., Muraglia, A., Campanile, G., Cancedda, R. and Quarto, R. 1997. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138: 4456-4462.
13. Matsushita, M., Tsuboyama, T., Kasai, R., Okumura, H., Yamamuro, T., Higuchi, K., Higuchi, K., Kohno, A., Yonezu, T., Utani, A., Umezawa, M. and Takeda, T. 1986. Age-related changes in bone mass in the senescence-accelerated mouse (SAM) - SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. Am. J. Pathol. 125: 276-283.
14. Mayahara, H., Ito, T., Nagai, H., Miyajima, H., Tsukuda, R., Taketomi, S., Mizuguchi, J. and Kato, K. 1993. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9: 73-80.
15. Mazué, G., Bertolero, F., Garofano, L., Brughera, M. and Carminati, P. 1992. Experience with the preclinical assessment of basic fibroblast growth factor (bFGF). Toxicol. Lett. 64/65: 329-338.
16. Nagai, H., Tsukuda, R. and Mayahara, H. 1995. Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats. Bone 16: 367-373.
17. Nakamura, T., Hanada, K., Tamura, M., Shibanushi, T., Nigi, H., Tagawa, M., Fukumoto, S. and Matsumoto, T. 1995. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136: 1276-1284.
18. Noda, M. and Vogel, R. 1989. Fibroblast growth factor enhances type β1 transforming growth factor gene expression in osteoblast-like cells. J. Cell Biol. 109: 2529-2535.
19. Parfitt, A. M., Drenzner, M. K., Glureiux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M. and Recker, R. P. 1987. Bone histomorphometry: Standardization of nomenclature, symbols, and units - Report of the ASBMR histomorphometry nomenclature committee. J. Bone Miner. Res. 2: 595-610.
20. Rodan, S. B., Wesolowski, G., Yoon, K. and Rodan, G. A. 1989. Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. J. Biol. Chem. 264: 19934-19941.
21. Rosen, D., Miller, S. C., DeLeon, E., Thompson, A. Y., Bentz, H., Mathews, M. and Adams, S. 1994. Systemic administration of recombinant transforming growth factor beta 2 (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 15: 355-359.
22. Seno, M., Sasada, R., Iwane, M., Sudo, K., Kurokawa, T., Ito, K. and Igarashi, K. 1988. Stabilizing basic fibroblast growth factor using protein engineering. Biochem. Biophys. Res. Commun. 151: 701-708.
23. Suda, T., Miyama, K., Uchiyama, Y., Katagiri, T., Yamaguchi, A. and Sato, T. 1994. Osteoporotic bone changes in SAMP6 are due to a decrease in osteoblast progenitor cells. pp. 47-52. In: The SAM Model of Senescence (Takeda, T. ed.), Elsevier Science, Tokyo.
24. Takahashi, K., Tsuboyama, T., Matsushita, M., Kasai, R., Okumura, H., Yamamuro, T., Okamoto, Y., Toriyama, K., Kitagawa, K. and Takeda, T. 1994. Modification of strain-specific femoral bone density by bone marrow-derived factors administered neonatally: a study on the spontaneously osteoporotic mouse, SAMP6. Bone Miner. 24: 245-255.
25. Takeda, T., Hosokawa, M. and Higuchi, K. 1997. Senescence-accelerated mouse (SAM): A novel murine model of senescence. Exp. Gerontol. 32: 105-109.
26. Tsuboyama, T., Takahashi, K., Matsushita, M., Okumura, H., Yamamuro, T., Umezawa, M. and Takeda, T. 1989. Decreased endosteal formation during cortical bone modelling in SAM-P/6 mice with a low peak bone mass. Bone Miner. 7: 1-12.
27. Tsukuda, R., Shino, A., Tsuda, M. and Matsuo, T. 1986. Bone changes in the senescence-accelerated mouse (SAM) reared under specific pathogen-free (SPF) conditions. J. Bone Miner. Melab. 4: 121-127.
28. Triffitt, J. T. 1996. The stem cell of the osteoblast. pp. 39-50. In: Principles of Bone Biology (Bilezikian, J. P., Raiz, L. G. and Rodan, G. A. eds.), Academic Press, San Diego.
29. Wieder, R., Wang, H., Shirke, S., Wang, Q., Menzel, T., Feirt, N., Jakubowski, A. A. and Gabrilove, J. L. 1997. Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells. Growth Factors 15: 41-60.